|
|
|
Volumn 3, Issue 5, 2004, Pages 355-356
|
|
Long-term, secondary treatment of deep venous thrombosis: do we know the appropriate duration of treatment or therapeutic regimen?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
WARFARIN;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
ANTICOAGULANTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RECURRENCE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
WARFARIN;
|
|
EID: 33745567198
PISSN: None
EISSN: 15410714
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
